Madrigal Pharmaceuticals
MDGL
MDGL
303 hedge funds and large institutions have $7.13B invested in Madrigal Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 105 increasing their positions, 109 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 317 → 303 (-14)
9% less capital invested
Capital invested by funds: $7.82B → $7.13B (-$690M)
22% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 51
Holders
303
Holding in Top 10
12
Calls
$294M
Puts
$155M
Top Buyers
| 1 | +$62.5M | |
| 2 | +$56.6M | |
| 3 | +$55.9M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$55.7M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$22.8M |
Top Sellers
| 1 | -$129M | |
| 2 | -$62.6M | |
| 3 | -$47.8M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$44.6M |
| 5 |
Morgan Stanley
New York
|
-$41.4M |
